Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al., 569 U.S. 12-398 (13 June 2013)

Case Description

The U.S. Supreme Court decided on 13 June 2013 unanimously that isolated naturally occurring genes are not patent eligible subject matter. Synthetically created composite DNA, however, is patent eligible.

Decision Year
Pre-grant flexibilities